As an innovative subtype of invasive brain-computer interfaces (BCIs), the Endovascular Brain-Computer Interface (EBCI) enables electrode delivery to target brain regions via endovascular intervention ...
Researchers areworking to develop new potential treatments to limit the enzyme PTP1B, which may contribute to memory loss in ...
Every three minutes, someone in the UK is diagnosed with dementia. It is not an easy diagnosis to receive for the patient or ...
This year, there won't be enough memory to meet worldwide demand because powerful AI chips made by the likes of Nvidia, AMD and Google need so much of it. Prices for computer memory, or RAM, are ...
Micron said on Wednesday that it plans to stop selling memory to consumers to focus on providing enough memory for high-powered AI chips. "Micron has made the difficult decision to exit the Crucial ...
Please provide your email address to receive an email when new articles are posted on . Response rates on the SRS-2 and CGI-S were significantly higher in those given memantine. Memantine was also ...
Memantine, a drug approved for Alzheimer’s disease, was associated with significant improvement in social functioning in some children and adolescents with autism spectrum disorder (ASD) without ...
Elevated pregenual anterior cingulate cortex levels were associated with a favorable treatment response. HealthDay News — Memantine improves social impairments in youth with autism spectrum disorder ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...
The dementia drug memantine showed promise for improving social functioning in a small trial of youth with autism. Nine of 16 children and adolescents treated with memantine met the response criteria ...
Memory loss is one of the most unsettling experiences a person can face. While it’s often linked to conditions such as dementia or Alzheimer’s disease, even minor lapses can feel alarming. Forgetting ...
For decades, dementia, especially Alzheimer’s disease, was treated as untouchable. Families watched loved ones fade, doctors could offer only reassurance and coping strategies, and research seemed to ...